Breallan De Jesús Romero Pájaro

Dr. Breallan De Jesús Romero Pájaro

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CVCarlos Vargas-Echeverría
Carlos Vargas-Echeverría
OSOscar Saurith-Coronell
Oscar Saurith-Coronell
OHOlimpo Rafael de Jesús Sierra Hernández
Olimpo Rafael de Jesús Sierra Hernández
JRJuan Felipe Santos Rodríguez
Juan Felipe Santos Rodríguez
JRJuan David Rodriguez
Juan David Rodriguez
EMEdgar Márquez
Edgar Márquez
Nipah virus (NiV) is a highly lethal zoonotic pathogen with significant pandemic potential, for which no approved antiviral therapies are currently available. Viral entry is mediated by the interaction between the NiV attachment glycoprotein (NiV-G) and host ephrin receptors, particularly ephrin-B2 (EFNB2) and ephrin-B3 (EFNB3), making this interface an attractive therapeutic target. In this study, we evaluated a set of structurally related flavonoids, apigenin, cynaroside, and lonicerin, as potential modulators of the EFNB2–NiV-G and EFNB3–NiV-G interactions. These compounds were selected based on their structural similarity, reported antiviral activity, chemical diversity, and favorable drug-like properties. Apigenin was employed as a reference scaffold due to its well-characterized pharmacological profile and its suitability for guiding analog-based compound selection. Apigenin served as a reference scaffold for selecting structurally related flavonoids, which were analyzed through density functional theory optimization, molecular docking, pharmacokinetic and toxicity predictions, molecular dynamics simulations, and binding free energy calculations. These flavonoids demonstrated high predicted affinity for both the EFNB2–NiV-G and EFNB3–NiV-G interfaces. According to results, these compounds consistently interacted with residues known to play a critical role in receptor recognition, with special emphasis on leucine and tryptophan residues within the G–H loop. These residues are well established as key determinants in the entry process of Nipah virus (NiV) into host cells, highlighting the potential relevance of these flavonoid–protein interactions. Molecular dynamics analyses indicated that flavonoid binding reduced the affinity and the conformational flexibility at the receptor–glycoprotein interfaces and decreased the stability of the complexes. Pharmacokinetic and toxicity predictions suggested favorable drug-like properties for the flavonoids, with apigenin displaying the most balanced profile. Collectively, these results support the potential of selected flavonoids as modulators of EFNB2–NiV-G and EFNB3–NiV-G interactions and provide a rationale for their prioritization in experimental studies aimed at developing scaffolds for the modulation of viral entry against Nipah virus.

23 April 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
BPBreallan De Jesús Romero Pájaro
Breallan De Jesús Romero Pájaro
DSDiana Carolina Caicedo Sanchez
Diana Carolina Caicedo Sanchez
MLMichael Mario Vélez Lora
Michael Mario Vélez Lora
JGJohn Freddy Mina Gasca
John Freddy Mina Gasca
Damian Ochoa GuetteDamian Ochoa Guette
Damian Ochoa Guette
JRJuan David Rodriguez
Juan David Rodriguez
Sepsis-associated acute kidney injury (SA-AKI) remains a major diagnostic challenge in critically ill patients, as conventional functional criteria—serum creatinine and urine output—often detect AKI after clinically relevant pathophysiological derangement has already evolved. Increasing evidence suggests that SA-AKI reflects a heterogeneous process characterized by early cellular stress, microcirculatory dysfunction, inflammation-associated injury, and maladaptive repair preceding overt functional decline. In this context, biomarker-based approaches have been investigated to improve early risk stratification, phenotypic characterization, and prognostic assessment in septic patients. This narrative review synthesizes current evidence on established and emerging biomarkers relevant to SA-AKI, encompassing stress markers ([TIMP-2]•[IGFBP7]), tubular injury markers (e.g., NGAL, KIM-1, IL-18), functional markers (e.g., proenkephalin/penKid, cystatin C), and exploratory molecular signatures such as circulating microRNAs (miRNAs). We examine their temporal dynamics, performance estimates, and context-dependent applicability in sepsis, and discuss limitations related to heterogeneity, assay variability, and threshold standardization. Particular attention is given to multimodal and longitudinal strategies integrating biomarkers with KDIGO criteria and clinical phenotyping. Finally, we outline a stratified framework for biomarker interpretation in SA-AKI anchored to pathophysiological windows and clinical decision points. While available evidence supports the potential of selected biomarkers for short-term risk stratification and trajectory assessment, implementation requires prospective validation demonstrating incremental value beyond established models and measurable impact on patient-centered outcomes.

23 June 2026 in Revista Colombiana de Hematología y Oncología
Verified
Journal Article
Open access
GGGillian Martinez Guerrero
Gillian Martinez Guerrero
ALAngel Luis Hernandez Lastra
Angel Luis Hernandez Lastra
BPBreallan De Jesús Romero Pájaro
Breallan De Jesús Romero Pájaro
CTCristian Garcia Torres
Cristian Garcia Torres
GNGermán Darío Idarraga Negrete
Germán Darío Idarraga Negrete
LPLileth Romero Pajaro
Lileth Romero Pajaro
Introducción El síndrome de Cogan-like es una enfermedad inflamatoria rara caracterizada por compromiso ocular y auditivo, cuya asociación con inhibidores de puntos de control inmunológicos es excepcional y plantea retos diagnósticos y terapéuticos. Caso clínico Se presenta el caso de un paciente masculino de 54 años con carcinoma renal de células claras estadio IV tratado con pembrolizumab, quien tras la décima dosis desarrolló uveítis bilateral, neuritis óptica, hipoacusia neurosensorial, tinnitus y mareo, con progresión hacia ceguera y sordera funcional; los estudios de imagen descartaron compromiso tumoral o infeccioso. Se suspendió la inmunoterapia e inició manejo multidisciplinario con pulsos de metilprednisolona (1gr/día por 5 días), seguidos de prednisona oral (1mg/kg/día, con reducción progresiva) y azatioprina (2 mg/kg/día) como ahorrador de esteroides. La evolución temporal y la exclusión de diagnósticos alternativos sustentaron el diagnóstico de síndrome de Cogan-like inducido por pembrolizumab, cuadro descrito en muy pocos reportes, en su mayoría asociados a nivolumab y con desenlaces frecuentemente irreversibles. Conclusión Este caso enfatiza la necesidad del reconocimiento temprano, la suspensión del fármaco y el inicio oportuno de inmunosupresores. En este caso tras la décima dosis, a los 9–10 meses de tratamiento- se desarrolló un evento adverso inmunomediado de aparición tardía, en el que la intervención multidisciplinaria resultó clave para disminuir el riesgo de secuelas permanentes.

28 September 2026 in Reports
Verified
Journal Article
Open access
PDF file
Damian Ochoa GuetteDamian Ochoa Guette
Damian Ochoa Guette
Jennifer Patricia Vargas GómezJennifer Patricia Vargas Gómez
Jennifer Patricia Vargas Gómez
BPBreallan De Jesús Romero Pájaro
Breallan De Jesús Romero Pájaro
RBrafael andres Tous bertel
rafael andres Tous bertel
AHAmilkar José Almanza hurtado
Amilkar José Almanza hurtado
Background and Clinical Significance: Secondary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome that can closely resemble sepsis in adults, potentially delaying recognition and treatment. Because infection may trigger or coexist with HLH, persistent or disproportionate inflammation despite appropriate antimicrobial therapy should prompt reassessment for concomitant HLH and investigation of the underlying trigger; Case Presentation: We describe three adults initially managed for presumed sepsis or severe infection at a referral hospital in Colombia. All developed persistent fever, cytopenias, organomegaly, and marked hyperferritinemia. HScore values were 222, 246, and 248, respectively; the score in Case 3 was calculated retrospectively from available pretreatment data. Bone marrow hemophagocytosis was demonstrated in Cases 1 and 2 but not in Case 3. The underlying triggers were acute myeloid leukemia, disseminated histoplasmosis in the setting of advanced HIV infection, and visceral leishmaniasis. The malignancy-associated case had an unfavorable outcome. Both infection-associated cases improved after pathogen-directed therapy combined with corticosteroids to control hyperinflammation, without escalation to an etoposide-based regimen; Conclusions: Sepsis and secondary HLH should not be regarded as mutually exclusive diagnoses. Persistent or disproportionate inflammation accompanied by progressive multilineage cytopenias, splenomegaly, markedly elevated or rising ferritin levels, hypertriglyceridemia, and/or decreasing fibrinogen should prompt early HScore calculation, assessment of HLH-2004 criteria, and concurrent investigation for an underlying trigger. Recognition of the clinical pattern and individualized treatment of both the trigger and hyperinflammatory state may facilitate timely management.

3 July 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Damian Ochoa GuetteDamian Ochoa Guette
Damian Ochoa Guette
Jennifer Patricia Vargas GómezJennifer Patricia Vargas Gómez
Jennifer Patricia Vargas Gómez
BPBreallan De Jesús Romero Pájaro
Breallan De Jesús Romero Pájaro
RBrafael andres Tous bertel
rafael andres Tous bertel
AHAmilkar José Almanza hurtado
Amilkar José Almanza hurtado
Background: Hemophagocytic lymphohistiocytosis is a life-threatening hyperinflammatory syndrome that can mimic sepsis in adults, delaying diagnosis and treatment. Methods: We reviewed three adult patients admitted to a high-complexity referral hospital in Colombia, all initially managed as sepsis, analyzing clinical findings, laboratory results, bone marrow studies, diagnostic approach, and outcomes. Results: All patients had persistent fever, cytopenias, organomegaly, hyperferritinemia, and hypertriglyceridemia, with ongoing inflammation despite appropriate antimicrobial therapy. Bone marrow examination showed hemophagocytosis in all cases. One case was associated with acute myeloid leukemia and had a poor outcome, while two infection-related cases, triggered by disseminated histoplasmosis and visceral leishmaniasis, improved with targeted therapy and supportive care. Conclusions: Persistent inflammation, cytopenias, and markedly elevated ferritin despite standard sepsis treatment should prompt early consideration of hemophagocytic lymphohistiocytosis and investigation of the underlying trigger.